Trial Information

Summary: Neurobiology of Depression and Antidepressants

This study uses brain-imaging technology (PET scans) to visualize and research brain biochemistry identified with depression. The goal is to use this technology to identify changes in brain chemistry that may cause an episode of depression. In exchange for study participation, patients receive no-cost outpatient treatment for six months, or inpatient treatment, depending on their clinical needs.

Benefits to participant:

• Free, thorough clinical evaluation by doctoral-level psychologist and/or psychiatrist
• No-cost inpatient or outpatient treatment

Patient Inclusion Criteria

• Ages 18 to 65
• Meets criteria for Major Depressive Disorder
• Currently depressed

Patient Exclusion Criteria

• Unstable Medical condition
• Pregnancy
• Current alcohol or substance abuse

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.